Skip to content

Clinical Efficacy and Mechanistic Study of Specific-Pattern Electroacupuncture for Promoting NGF Delivery to the Brain in Dysphagia After Supratentorial Stroke

Clinical Efficacy and Mechanistic Study of Specific-Pattern Electroacupuncture for Promoting NGF Delivery to the Brain in Dysphagia After Supratentorial Stroke

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2026001097
Enrollment
Unknown
Registered
2026-04-28
Start date
2026-01-01
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

post stroke dysphagia

Interventions

Test group:Specific Mode Electric Needles Combined with NGF

Sponsors

The Third Affiliated Hospital of Zhejiang Chinese Medicine University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1 inclusion criteria (1) meets the aforementioned diagnostic criteria, and cranial brain MRI confirms that the lesion is not in the brain stem and/or cerebellum ; (2) Age between 18 and 90 years, regardless of gender ; (3) 1-12 months of pathology ; (4) Diagnosis of swallowing disorder is evaluated by physicians and speech therapists, and confirmed by VFSS or FEES ; (5) No history of swallowing difficulties due to any neurological disorder or structural abnormalities or damage to the head and neck ; (6) No history of neuropsychological or psychiatric disorders ; (7) able to understand instructions, cooperate with various assessments, and inspections ; (8) Able to receive acupuncture, electro-stimulation therapy and hip muscle injections and is compliant ; (9) the patient or legal agent gives informed consent and signs a informed consent form.

Exclusion criteria

Exclusion criteria: 2 Exclusion Criteria (1) Previous to this illness, there was a swallowing disorder, or a swallowing disorder caused by a non-ischemic stroke, such as in the head and neck Tumors, esophageal tumors, myasthenia gravis, Guillain-Barré syndrome, etc. ; (2) Patients with severe heart, liver, kidney dysfunction and severe coagulation dysfunction ; (3) Other abnormalities examined by researchers as deemed unsuitable for participation in this study ; (4) Multiple relapses of stroke, brain surgery, or cerebral infarction caused by trauma, brain tumor, etc. ; (5) People with severe neurological deficits prior to stroke, such as vision, hearing impairment, speech loss, loss of cognition, and severe bias paralysis etc. ; (6) pregnant, planned pregnancy, or breastfeeding women ; (7) who have history of dizziness from needles, and who have skin infections at the punctured areas ; (8) carriers of implanted cardiac resuscitation defibrillators, internal conductive metal foreign objects or pacemakers ; Version Number: Applicant: Version Date: (9) Patients with NGF allergies; (10) who are participating in other clinical trials or who have participated in other clinical trials less than 3 months after the conclusion ;

Design outcomes

Primary

MeasureTime frame
Functional Oral Intake Scale;

Secondary

MeasureTime frame
Standard Swallowing Function Assessment;Leak Aspiration Score (PAS);Wada drinking test;

Countries

China

Contacts

Public ContactPeng Gong

The Third Affiliated Hospital of Zhejiang Chinese Medicine University

Ericgong0613@163.com18804608937

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Jun 11, 2026